| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615559 | Clinical Lymphoma Myeloma and Leukemia | 2018 | 48 Pages |
Abstract
In patients with RRMM who are suitable for an IMiD-containing regimen, DRd showed clear advantages in survival and response outcomes compared with other IMiD-containing regimens.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Meletios Athanasios Dimopoulos, Jonathan L. Kaufman, Darrell White, Gordon Cook, Maria Rizzo, Yingxin Xu, Kyle Fahrbach, Maren Gaudig, Mary Slavcev, Lindsay Dearden, Annette Lam,